Skip to content

A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position

A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02809287
Enrollment
10
Registered
2016-06-22
Start date
2015-01-31
Completion date
2016-01-31
Last updated
2016-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

Since the first report of laparoscopic resection of a benign hepatic tumor by Professor H. Reith in 1991, the laparoscope has been widely used in liver disease. Based on its advantages in laparoscopic vision and amplification, laparoscopic hepatectomy (LH) has been well recognized globally. Generally speaking, for lesions located in the left, front or lower part of the liver, corresponding to Couinaud segments II, III, IVb, V and VI, an LH surgery is recommended; however, for lesions located in segments VII and VIII, the surgery is high technically difficult due to poor exposure. Therefore,the investigators employ the left lateral position plus jackknife position to better expose lesions in these segments, hoping to reduce surgical time and bleeding in LH.

Interventions

PROCEDUREJackknife posture

patients with left lateral position plus jackknife position when perform laparoscopic hepatectomy

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients were diagnosed with hepatocellular carcinoma (HCC) based on the criteria established by the European Association for the Study of the Liver 2. Tumor located in segment VI, VII, or VIII.

Exclusion criteria

1. Major vessel or bile duct tumor invasion, 2. Recurrent HCC 3. Tumor close to secondary vessels and bile ducts 4. Patients with extrahepatic metastasis 5. Grade C liver function, 6. Significant surgical contraindications

Design outcomes

Primary

MeasureTime frameDescription
Operation timeintraoperativeevaluate the efficiency with this posture
Blood lossintraoperativeevaluate the blood loss with this posture

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026